Logo of jibtherBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleJournal of Immune Based Therapies and VaccinesJournal Front Page
PMC full text:

Figure 2

An external file that holds a picture, illustration, etc.
Object name is 1476-8518-9-4-2.jpg

Increased protection in animals as depicted by numbers of viable CFUs of M. tuberculosis H37Rv in the lungs of M. tuberculosis H37Rv infected animals receiving adjunctive immunotherapy. Two weeks post chemotherapy/immunotherapy, lungs and spleen from treated and untreated M. tuberculosis H37Rv infected animals were isolated and cultured on Middlebrook 7H11 agar plates. Results are expressed as mean log10 CFUs ± standard deviation of 5 animals per group tested individually. Statistical analysis of the results was carried out by Student's t test. ***p< 0.001, **p< 0.01 compared to untreated animals. Basal level represents CFU after two weeks of infection. (ATD: Antituberculous Drugs; IT: Immunotherapy; O/W: Once Weekly)

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
Click on the image to see a larger version.